Frontiers in Immunology (Jun 2024)

Advancing precision rheumatology: applications of machine learning for rheumatoid arthritis management

  • Yiming Shi,
  • Yiming Shi,
  • Yiming Shi,
  • Mi Zhou,
  • Mi Zhou,
  • Cen Chang,
  • Cen Chang,
  • Ping Jiang,
  • Ping Jiang,
  • Ping Jiang,
  • Kai Wei,
  • Kai Wei,
  • Kai Wei,
  • Jianan Zhao,
  • Jianan Zhao,
  • Jianan Zhao,
  • Yu Shan,
  • Yu Shan,
  • Yu Shan,
  • Yixin Zheng,
  • Yixin Zheng,
  • Yixin Zheng,
  • Fuyu Zhao,
  • Fuyu Zhao,
  • Fuyu Zhao,
  • Xinliang Lv,
  • Shicheng Guo,
  • Fubo Wang,
  • Fubo Wang,
  • Dongyi He,
  • Dongyi He,
  • Dongyi He

DOI
https://doi.org/10.3389/fimmu.2024.1409555
Journal volume & issue
Vol. 15

Abstract

Read online

Rheumatoid arthritis (RA) is an autoimmune disease causing progressive joint damage. Early diagnosis and treatment is critical, but remains challenging due to RA complexity and heterogeneity. Machine learning (ML) techniques may enhance RA management by identifying patterns within multidimensional biomedical data to improve classification, diagnosis, and treatment predictions. In this review, we summarize the applications of ML for RA management. Emerging studies or applications have developed diagnostic and predictive models for RA that utilize a variety of data modalities, including electronic health records, imaging, and multi-omics data. High-performance supervised learning models have demonstrated an Area Under the Curve (AUC) exceeding 0.85, which is used for identifying RA patients and predicting treatment responses. Unsupervised learning has revealed potential RA subtypes. Ongoing research is integrating multimodal data with deep learning to further improve performance. However, key challenges remain regarding model overfitting, generalizability, validation in clinical settings, and interpretability. Small sample sizes and lack of diverse population testing risks overestimating model performance. Prospective studies evaluating real-world clinical utility are lacking. Enhancing model interpretability is critical for clinician acceptance. In summary, while ML shows promise for transforming RA management through earlier diagnosis and optimized treatment, larger scale multisite data, prospective clinical validation of interpretable models, and testing across diverse populations is still needed. As these gaps are addressed, ML may pave the way towards precision medicine in RA.

Keywords